Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 351 items for :

  • hormone replacement therapy x
Clear All
Nathalie Ly Department of Endocrinology and Reproductive Medicine, Reference Center for Rare Endocrine Diseases of Growth and Development, Reference Center for Gynecological Rare Diseases, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France

Search for other papers by Nathalie Ly in
Google Scholar
PubMed Close
,
Sophie Dubreuil Department of Endocrinology and Reproductive Medicine, Reference Center for Rare Endocrine Diseases of Growth and Development, Reference Center for Gynecological Rare Diseases, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France

Search for other papers by Sophie Dubreuil in
Google Scholar
PubMed Close
, and
Philippe Touraine Department of Endocrinology and Reproductive Medicine, Reference Center for Rare Endocrine Diseases of Growth and Development, Reference Center for Gynecological Rare Diseases, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Sorbonne University, Paris, France

Search for other papers by Philippe Touraine in
Google Scholar
PubMed Close

://doi.org/10.1016/j.fertnstert.2004.03.026 ) 16 Wirén L Boguszewski CL Johannsson G . Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy . Clinical Endocrinology 2002 57 235 – 239 . ( https://doi.org/10.1046/j.1365

Article Type:
Research Article
Collections:
Reproduction
DOI:
https://doi.org/10.1530/EC-22-0241
Volume/Issue:
Volume 11: Issue 12
Open access
Kjersti S Bakken Women’s Clinic, Innlandet Hospital Trust, Lillehammer, Norway
Center for International Health, University of Bergen, Bergen, Norway

Search for other papers by Kjersti S Bakken in
Google Scholar
PubMed Close
,
Kristina Randjelovic Nermo Center for International Health, University of Bergen, Bergen, Norway
Department of Microbiology, Innlandet Hospital Trust, Lillehammer, Norway

Search for other papers by Kristina Randjelovic Nermo in
Google Scholar
PubMed Close
,
Bjørn Gunnar Nedrebø Department of Medicine, Haugesund Hospital, Haugesund, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Bjørn Gunnar Nedrebø in
Google Scholar
PubMed Close
,
Tim I M Korevaar Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands

Search for other papers by Tim I M Korevaar in
Google Scholar
PubMed Close
, and
Tor A Strand Center for International Health, University of Bergen, Bergen, Norway
Department of Research, Innlandet Hospital Trust, Lillehammer, Norway

Search for other papers by Tor A Strand in
Google Scholar
PubMed Close

provided with two separate files which were combined using the pseudonymized patient identification numbers. Thyroid treatment was coded into three categories based on the ATC-codes: (i) thyroid hormone replacement therapy, which included women that had

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-21-0631
Volume/Issue:
Volume 11: Issue 4
Open access
Guido Zavatta Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

Search for other papers by Guido Zavatta in
Google Scholar
PubMed Close
and
Bart L Clarke Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Bart L Clarke in
Google Scholar
PubMed Close

replacement therapy. Since then a growing body of clinical studies has been published describing the long-term effects of recombinant human parathyroid hormone rhPTH(1–84), other forms of parathyroid hormone-based therapies, and PTH receptor 1 (PTHR1) agonist

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0366
Volume/Issue:
Volume 9: Issue 10
Open access
Ulla Schmidt Endocrine Unit, Department of Medicine, Endocrine Unit, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, Herlev Ringvej, DK-2730 Herlev, Denmark

Search for other papers by Ulla Schmidt in
Google Scholar
PubMed Close
,
Birte Nygaard Endocrine Unit, Department of Medicine, Endocrine Unit, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, Herlev Ringvej, DK-2730 Herlev, Denmark

Search for other papers by Birte Nygaard in
Google Scholar
PubMed Close
,
Ebbe Winther Jensen Endocrine Unit, Department of Medicine, Endocrine Unit, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, Herlev Ringvej, DK-2730 Herlev, Denmark

Search for other papers by Ebbe Winther Jensen in
Google Scholar
PubMed Close
,
Jan Kvetny Endocrine Unit, Department of Medicine, Endocrine Unit, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, Herlev Ringvej, DK-2730 Herlev, Denmark

Search for other papers by Jan Kvetny in
Google Scholar
PubMed Close
,
Anne Jarløv Endocrine Unit, Department of Medicine, Endocrine Unit, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, Herlev Ringvej, DK-2730 Herlev, Denmark

Search for other papers by Anne Jarløv in
Google Scholar
PubMed Close
, and
Jens Faber Endocrine Unit, Department of Medicine, Endocrine Unit, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, Herlev Ringvej, DK-2730 Herlev, Denmark
Endocrine Unit, Department of Medicine, Endocrine Unit, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, Herlev Ringvej, DK-2730 Herlev, Denmark

Search for other papers by Jens Faber in
Google Scholar
PubMed Close

CC Koutras DA . TSH may not be a good marker for adequate thyroid hormone replacement therapy . Wien Klinicher Wochenschrifte 2005 117 636 – 640 . ( doi:10.1007/s00508-005-0421-0 ). 17 Krotkiewski M Holm G Shono N . Small doses of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-12-0064
Volume/Issue:
Volume 2: Issue 1
Open access
Trine Holm Johannsen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed Close
,
Jakob Albrethsen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jakob Albrethsen in
Google Scholar
PubMed Close
,
Vassos Neocleous The Cyprus Institute of Neurology and Genetics, Department of Molecular Genetics, Function and Therapy, Nicosia, Cyprus

Search for other papers by Vassos Neocleous in
Google Scholar
PubMed Close
,
Federico Baronio S. Orsola-Malpighi University Hospital, Department of Medical and Surgical Sciences, Bologna, Italy

Search for other papers by Federico Baronio in
Google Scholar
PubMed Close
,
Martine Cools Department of Pediatrics, Division of Pediatric Endocrinology, Ghent University Hospital and Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium

Search for other papers by Martine Cools in
Google Scholar
PubMed Close
,
Lise Aksglaede Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Lise Aksglaede in
Google Scholar
PubMed Close
,
Niels Jørgensen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Niels Jørgensen in
Google Scholar
PubMed Close
,
Peter Christiansen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Peter Christiansen in
Google Scholar
PubMed Close
,
Meropi Toumba The Cyprus Institute of Neurology and Genetics, Department of Molecular Genetics, Function and Therapy, Nicosia, Cyprus
Pediatric Endocrinology Clinic, Department of Pediatrics, Aretaeio Hospital, Nicosia, Cyprus

Search for other papers by Meropi Toumba in
Google Scholar
PubMed Close
,
Pavlos Fanis The Cyprus Institute of Neurology and Genetics, Department of Molecular Genetics, Function and Therapy, Nicosia, Cyprus

Search for other papers by Pavlos Fanis in
Google Scholar
PubMed Close
,
Marie Lindhardt Ljubicic Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Marie Lindhardt Ljubicic in
Google Scholar
PubMed Close
, and
Anders Juul Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Denmark

Search for other papers by Anders Juul in
Google Scholar
PubMed Close

adrenocorticotropic hormone and, thus, an overproduction of adrenal androgens, which may result in virilization, an altered growth pattern, and infertility ( 2 ). Treatment of CAH may comprise life-long replacement therapy with glucocorticoids and mineralocorticoids

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-23-0073
Volume/Issue:
Volume 12: Issue 8
Open access
Kathrin R Frey Department of Medicine I, Endocrine and Diabetes Unit, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Kathrin R Frey in
Google Scholar
PubMed Close
,
Tina Kienitz Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Tina Kienitz in
Google Scholar
PubMed Close
,
Julia Schulz Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Julia Schulz in
Google Scholar
PubMed Close
,
Manfred Ventz Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Manfred Ventz in
Google Scholar
PubMed Close
,
Kathrin Zopf Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Kathrin Zopf in
Google Scholar
PubMed Close
, and
Marcus Quinkler Endocrinology in Charlottenburg, Berlin, Germany

Search for other papers by Marcus Quinkler in
Google Scholar
PubMed Close

Introduction In states of adrenal insufficiency (AI), such as primary adrenal insufficiency (PAI) and congenital adrenal hyperplasia (CAH), glucocorticoids (GCs) are given in low doses as hormone replacement therapy. However, the daily intake

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0160
Volume/Issue:
Volume 7: Issue 6
Open access
Luca Persani Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Luca Persani in
Google Scholar
PubMed Close
,
Biagio Cangiano Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Biagio Cangiano in
Google Scholar
PubMed Close
, and
Marco Bonomi Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Marco Bonomi in
Google Scholar
PubMed Close

-term growth hormone (GH) replacement therapy in GH deficient children . Clinical Endocrinology 2000 53 183 – 189 . ( https://doi.org/10.1046/j.1365-2265.2000.01071.x ) 10.1046/j.1365-2265.2000.01071.x 10931099 61 Benaglia L Busnelli A Somigliana E

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-18-0515
Volume/Issue:
Volume 8: Issue 2
Open access
M Ahmid Developmental Endocrinology Research Group, Royal Hospital for Children, School of Medicine, University of Glasgow, Glasgow, UK

Search for other papers by M Ahmid in
Google Scholar
PubMed Close
,
C G Perry Department of Endocrinology, Queen Elizabeth University Hospitals, Glasgow, UK

Search for other papers by C G Perry in
Google Scholar
PubMed Close
,
S F Ahmed Developmental Endocrinology Research Group, Royal Hospital for Children, School of Medicine, University of Glasgow, Glasgow, UK

Search for other papers by S F Ahmed in
Google Scholar
PubMed Close
, and
M G Shaikh Developmental Endocrinology Research Group, Royal Hospital for Children, School of Medicine, University of Glasgow, Glasgow, UK

Search for other papers by M G Shaikh in
Google Scholar
PubMed Close

Wilton P Kims Study Group & KIMS International Board The infuence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density . Journal of Bone and Mineral

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-16-0024
Volume/Issue:
Volume 5: Issue 3
Open access
Charlotte Höybye Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Search for other papers by Charlotte Höybye in
Google Scholar
PubMed Close
,
Andreas F H Pfeiffer Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Klinik für Endokrinologie & Stoffwechselmedizin, Berlin, Germany

Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed Close
,
Diego Ferone IRCCS AOU San Martino-IST, Università di Genova – Endocrinologia DiMI, Dipartimento di Medicina Interna e Specialità Mediche, & CEBR, Centro di Eccellenza per la Ricerca Biomedica, Genova, Italy

Search for other papers by Diego Ferone in
Google Scholar
PubMed Close
,
Jens Sandahl Christiansen Medicinsk Endokrinologist Afd., MEA, NBG, Århus Sygehus, Århus, Denmark

Search for other papers by Jens Sandahl Christiansen in
Google Scholar
PubMed Close
,
David Gilfoyle Ascendis Pharma A/S, Hellerup, Denmark

Search for other papers by David Gilfoyle in
Google Scholar
PubMed Close
,
Eva Dam Christoffersen Ascendis Pharma A/S, Hellerup, Denmark

Search for other papers by Eva Dam Christoffersen in
Google Scholar
PubMed Close
,
Eva Mortensen Ascendis Pharma Inc., Palo Alto, California, USA

Search for other papers by Eva Mortensen in
Google Scholar
PubMed Close
,
Jonathan A Leff Ascendis Pharma Inc., Palo Alto, California, USA

Search for other papers by Jonathan A Leff in
Google Scholar
PubMed Close
, and
Michael Beckert Ascendis Pharma A/S, Hellerup, Denmark

Search for other papers by Michael Beckert in
Google Scholar
PubMed Close

and 70 years with a body mass index (BMI) of 19.0–36.0 kg/m 2 ) diagnosed with AGHD (defined according to the Growth Hormone Research Society Consensus Guidelines of 1998 and 2007) ( 1 , 12 ) who were stable on GH replacement therapy for at least 3

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0007
Volume/Issue:
Volume 6: Issue 3
Open access
Anna Olsson-Brown Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK
The Clatterbridge Cancer Centre, Wirral, UK

Search for other papers by Anna Olsson-Brown in
Google Scholar
PubMed Close
,
Rosemary Lord The Clatterbridge Cancer Centre, Wirral, UK

Search for other papers by Rosemary Lord in
Google Scholar
PubMed Close
,
Joseph Sacco The Clatterbridge Cancer Centre, Wirral, UK
Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK

Search for other papers by Joseph Sacco in
Google Scholar
PubMed Close
,
Jonathan Wagg Roche Innovation Center, Basel, Switzerland

Search for other papers by Jonathan Wagg in
Google Scholar
PubMed Close
,
Mark Coles Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK

Search for other papers by Mark Coles in
Google Scholar
PubMed Close
, and
Munir Pirmohamed Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK

Search for other papers by Munir Pirmohamed in
Google Scholar
PubMed Close

monitored for thyroid dysfunction throughout their course of therapy because of the variable temporal relationship, so that symptomatic management of the hyperthyroid phase and timely institution of hormone replacement in the hypothyroid phase can be

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0473
Volume/Issue:
Volume 9: Issue 4
Open access